Atlas Trials

A Registry Study in Lymphoma Patients Treated With Liposomal Doxorubicin

Clinical trial NCT04069845 · UNKNOWN

Trial details

NCT number
NCT04069845
Sponsor
Ruijin Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Lymphoma
Start date
2019-08-01
Primary completion
2021-08-01
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.